Patient Webinar: Introduction to the RUNX1-FPD imatinib Clinical Study
Friday, May 17th • 7 a.m. PT | 10 a.m. ET
Join this webinar to learn more about the groundbreaking Phase 1b clinical trial investigating the potential of the drug imatinib to increase RUNX1 protein levels in individuals with RUNX1-FPD.
Dr. Lea Cunningham, Principal Investigator, and Dr. Alan Cantor, Associate Investigator, will dive into the rationale behind this trial, discuss participant eligibility criteria, and answer general questions about engaging in a clinical trial.
Whether you're considering participation or simply seeking to learn more, this webinar is an invaluable opportunity to engage directly with its leaders!
